Literature DB >> 19224157

Curcumin-induced histone acetylation in malignant hematologic cells.

Junbin Hu1, Yan Wang, Yan Chen.   

Abstract

This study investigated the inhibitory effects of curcumin on proliferation of hematological malignant cells in vitro and the anti-tumor mechanism at histone acetylation/histone deacetylation levels. The effects of curcumin and histone deacetylase inhibitor trichostatin A (TSA) on the growth of Raji cells were tested by MTT assay. The expression of acetylated histone-3 (H(3)) in Raji, HL60 and K562 cells, and peripheral blood mononuclear cells (PBMCs) treated with curcumin or TSA was detected by immunohistochemistry and FACS. The results showed curcumin inhibited proliferation of Raji cells significantly in a time- and dose-dependent fashion, while exhibited low toxicity in PBMCs. Curcumin induced up-regulation of the expression of acetylated H(3) dose-dependently in all malignant cell lines tested. In conclusion, curcumin inhibited proliferation of Raji cells selectively, enhanced the level of acetylated (H(3)) in Raji, HL60, and K562 cells, which acted as a histone deacetylase inhibitor like TSA. Furthermore, up-regulation of H(3) acetylation may play an important role in regulating the proliferation of Raji cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224157     DOI: 10.1007/s11596-009-0105-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

Review 1.  Histone deacetylases, transcriptional control, and cancer.

Authors:  W D Cress; E Seto
Journal:  J Cell Physiol       Date:  2000-07       Impact factor: 6.384

2.  Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.

Authors:  Q Zhou; Z K Melkoumian; A Lucktong; M Moniwa; J R Davie; J S Strobl
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

Review 3.  Anticancer potential of curcumin: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anushree Kumar; Alok C Bharti
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

4.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors.

Authors:  M S Finnin; J R Donigian; A Cohen; V M Richon; R A Rifkind; P A Marks; R Breslow; N P Pavletich
Journal:  Nature       Date:  1999-09-09       Impact factor: 49.962

5.  Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation.

Authors:  Hong-li Liu; Yan Chen; Guo-hui Cui; Jian-feng Zhou
Journal:  Acta Pharmacol Sin       Date:  2005-05       Impact factor: 6.150

6.  Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.

Authors:  S S Han; S T Chung; D A Robertson; D Ranjan; S Bondada
Journal:  Clin Immunol       Date:  1999-11       Impact factor: 3.969

7.  Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report.

Authors:  R L Piekarz; R Robey; V Sandor; S Bakke; W H Wilson; L Dahmoush; D M Kingma; M L Turner; R Altemus; S E Bates
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

8.  Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo.

Authors:  Yuka Sasakawa; Yoshinori Naoe; Takeshi Inoue; Tatsuya Sasakawa; Masahiko Matsuo; Toshitaka Manda; Seitaro Mutoh
Journal:  Biochem Pharmacol       Date:  2002-10-01       Impact factor: 5.858

9.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.

Authors:  C-Y Gui; L Ngo; W S Xu; V M Richon; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

  9 in total
  4 in total

Review 1.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

2.  Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.

Authors:  Lihua Wang; Xiwen Chen; Zhuanyun Du; Gefei Li; Mayun Chen; Xi Chen; Guang Liang; Tongke Chen
Journal:  J Exp Clin Cancer Res       Date:  2017-03-31

Review 3.  Epigenetic associations in relation to cardiovascular prevention and therapeutics.

Authors:  Susanne Voelter-Mahlknecht
Journal:  Clin Epigenetics       Date:  2016-01-15       Impact factor: 6.551

Review 4.  Curcumin and colorectal cancer: An update and current perspective on this natural medicine.

Authors:  Wenhao Weng; Ajay Goel
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.